| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinib
|
Hülsmann, Helen J.
|
|
2014
|
86 |
2 |
p. 151-157
7 p.
|
artikel
|
| 2 |
Alterations of LKB1 and KRAS and risk of brain metastasis: Comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma
|
Zhao, Ni
|
|
2014
|
86 |
2 |
p. 255-261
7 p.
|
artikel
|
| 3 |
A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: Re-evaluation of EGFR gene status (NEJ006/TCOG0903)
|
Matsumoto, Yoshifumi
|
|
2014
|
86 |
2 |
p. 195-200
6 p.
|
artikel
|
| 4 |
A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer
|
Mahar, Alyson L.
|
|
2014
|
86 |
2 |
p. 281-287
7 p.
|
artikel
|
| 5 |
Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?
|
Halpenny, Darragh F.
|
|
2014
|
86 |
2 |
p. 190-194
5 p.
|
artikel
|
| 6 |
A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)
|
Hu, Xingsheng
|
|
2014
|
86 |
2 |
p. 207-212
6 p.
|
artikel
|
| 7 |
A single-arm phase II trial of pazopanib in patients with advanced non-small cell lung cancer with non-squamous histology with disease progression on bevacizumab containing therapy
|
Weiss, Jared M.
|
|
2014
|
86 |
2 |
p. 288-290
3 p.
|
artikel
|
| 8 |
Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer
|
Digumarti, Raghunadharao
|
|
2014
|
86 |
2 |
p. 231-236
6 p.
|
artikel
|
| 9 |
Bone metastasis, skeletal-related events, and mortality in lung cancer patients: A Danish population-based cohort study
|
Cetin, Karynsa
|
|
2014
|
86 |
2 |
p. 247-254
8 p.
|
artikel
|
| 10 |
Brain metastases following radical surgical treatment of non-small cell lung cancer: Is preoperative brain imaging important?
|
O’Dowd, Emma L.
|
|
2014
|
86 |
2 |
p. 185-189
5 p.
|
artikel
|
| 11 |
Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors
|
Chong, Curtis R.
|
|
2014
|
86 |
2 |
p. 241-246
6 p.
|
artikel
|
| 12 |
Concomitant EGFR mutation and ALK rearrangement in lung adenocarcinoma is more frequent than expected: Report of a case and review of the literature with demonstration of genes alteration into the same tumor cells
|
Baldi, Licia
|
|
2014
|
86 |
2 |
p. 291-295
5 p.
|
artikel
|
| 13 |
Contents
|
|
|
2014
|
86 |
2 |
p. v-vii
nvt p.
|
artikel
|
| 14 |
Depression, anxiety and disease-related distress in couples affected by advanced lung cancer
|
Haun, Markus W.
|
|
2014
|
86 |
2 |
p. 274-280
7 p.
|
artikel
|
| 15 |
Editorial Board
|
|
|
2014
|
86 |
2 |
p. iii-
1 p.
|
artikel
|
| 16 |
Efficacy and safety of erlotinib in elderly patients in the phase IV POLARSTAR surveillance study of Japanese patients with non-small-cell lung cancer
|
Yoshioka, Hiroshige
|
|
2014
|
86 |
2 |
p. 201-206
6 p.
|
artikel
|
| 17 |
EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC)
|
Reynolds, Jordan P.
|
|
2014
|
86 |
2 |
p. 158-163
6 p.
|
artikel
|
| 18 |
Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy
|
Xu, Chunhua
|
|
2014
|
86 |
2 |
p. 268-273
6 p.
|
artikel
|
| 19 |
Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: A prospective multicenter study in a real-world setting (GFPC study 12-01)
|
Chouaid, Christos
|
|
2014
|
86 |
2 |
p. 170-173
4 p.
|
artikel
|
| 20 |
Genetic profiling of thymic carcinoma using targeted next-generation sequencing
|
Shitara, Masayuki
|
|
2014
|
86 |
2 |
p. 174-179
6 p.
|
artikel
|
| 21 |
Heat shock protein 70 as a predictive marker for platinum-based adjuvant chemotherapy in patients with resected non-small cell lung cancer
|
Park, Tai Sun
|
|
2014
|
86 |
2 |
p. 262-267
6 p.
|
artikel
|
| 22 |
MEK inhibition in non-small cell lung cancer
|
Stinchcombe, Thomas E.
|
|
2014
|
86 |
2 |
p. 121-125
5 p.
|
artikel
|
| 23 |
Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner
|
Tsai, Ming-Ju
|
|
2014
|
86 |
2 |
p. 137-143
7 p.
|
artikel
|
| 24 |
Non-small cell lung cancer: When to offer sublobar resection
|
Sihoe, Alan D.L.
|
|
2014
|
86 |
2 |
p. 115-120
6 p.
|
artikel
|
| 25 |
Number of liver metastatic nodules affects treatment options for pulmonary adenocarcinoma patients with liver metastases
|
Tseng, Shih-En
|
|
2014
|
86 |
2 |
p. 225-230
6 p.
|
artikel
|
| 26 |
Possible differential EGFR-TKI efficacy among exon 19 deletional locations in EGFR-mutant non-small cell lung cancer
|
Kaneda, Toshihiko
|
|
2014
|
86 |
2 |
p. 213-218
6 p.
|
artikel
|
| 27 |
Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT
|
Kishimoto, Mariko
|
|
2014
|
86 |
2 |
p. 180-184
5 p.
|
artikel
|
| 28 |
Reduced chemotherapy sensitivity in EGFR-mutant lung cancer patient with frontline EGFR tyrosine kinase inhibitor
|
Zeng, Zhu
|
|
2014
|
86 |
2 |
p. 219-224
6 p.
|
artikel
|
| 29 |
Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients
|
Chao, Liu
|
|
2014
|
86 |
2 |
p. 164-169
6 p.
|
artikel
|
| 30 |
RETRACTED: β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome
|
Li, Jianying
|
|
2014
|
86 |
2 |
p. 144-150
7 p.
|
artikel
|
| 31 |
Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials
|
Mansfield, Aaron S.
|
|
2014
|
86 |
2 |
p. 133-136
4 p.
|
artikel
|
| 32 |
Targeting hypoxia in the treatment of small cell lung cancer
|
Bryant, J.L.
|
|
2014
|
86 |
2 |
p. 126-132
7 p.
|
artikel
|
| 33 |
Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase
|
Zauderer, Marjorie G.
|
|
2014
|
86 |
2 |
p. 237-240
4 p.
|
artikel
|
Tijdschrift beschrijving